NeuroScientific Biopharmaceuticals Limited logo

NSBNeuroScientific Biopharmaceuticals Limited

NSB Stock Price, Valuation & Chart | NeuroScientific Biopharmaceuticals Limited

Compare

NSB Historical price chart

NSB Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization25.33M
PE Ratio-4.28
EPS-0.02
Trading Volume1.29M
Today's High/Low0.07/0.06
Dividend Yield0.00
52 Week High/Low0.19/0.06
Shares Outstanding389.72M
NSB Financial Statement

NSB Analyst ratings

Buy

Strong buy
0
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 0 analysts giving stock ratings to NSB in the past 3 months.

NSB Analysis & performance metrics

NSB Company profile

NeuroScientific Biopharmaceuticals Limited develops therapeutic treatments for neurodegenerative diseases through preclinical and clinical studies of patented technologies.…

NSB Management team

Management
Anthony James KeatingCTO
Executive Director
Christopher Bryan James Achurch B.Com., C.A.
Company Secretary
Total 2 executives

NSB Frequently asked questions

What is NeuroScientific Biopharmaceuticals Limited (NSB) Stock Price?

Current stock price of NeuroScientific Biopharmaceuticals Limited (NSB) stock is $0.070. The stock price is +1.56% higher in the session. The intraday range can be seen from this page. Volume of NeuroScientific Biopharmaceuticals Limited (NSB) stock is 1.29M.

Last updated at 02 Sept 2026, 06:10 am.

Why is the NeuroScientific Biopharmaceuticals Limited (NSB) stock price going up or down today?

The stock price of NeuroScientific Biopharmaceuticals Limited (NSB) can change with earnings, company news, and overall market sentiment. NeuroScientific Biopharmaceuticals Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the NeuroScientific Biopharmaceuticals Limited stock expensive at its current price?

Whether NeuroScientific Biopharmaceuticals Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for NSB on this page is -4.28. EPS on this page is -0.02. Compare those figures with peers and growth expectations before deciding if the current NeuroScientific Biopharmaceuticals Limited price is justified.

How has the stock price of NeuroScientific Biopharmaceuticals Limited (NSB) performed historically?

Historical performance for NeuroScientific Biopharmaceuticals Limited (NSB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how NSB reacted to past earnings and market events.

Should I buy NeuroScientific Biopharmaceuticals Limited (NSB) stock, at this price?

Buying NeuroScientific Biopharmaceuticals Limited (NSB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.